Applications of telomerase in urologie oncology

World Journal of Urology

Volumn 15, Issue 2, 1997, Pages 120-124

  Landman, Jaime ^a   Kavaler, Elizabeth ^a   Droller, Michael J ^a   Liu, Brian C S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; TELOMERASE;

CHEMISTRY; DRUG ANTAGONISM; HUMAN; METHODOLOGY; NEOPLASM; ONCOLOGY; REVIEW; URINARY TRACT CANCER; UROLOGY;

ENZYME INHIBITORS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; TELOMERASE; UROLOGIC NEOPLASMS; UROLOGY;

EID: 0030626917     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02201983     Document Type: Article

References (39)

1. Adamson DJA, King DJ, Hakes NE (1992) Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 61: 204-205
2. Allsopp RC. Vaziri H, Patterson C, Goldstein S. Younglai EV. Futcher AB. Greider CW. Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sei USA 89: 10114-10118
3. Badalament RA. Fair WF, Whitmore WF Jr. Melamed MR (1988) The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Ketlering Cancer Center experience. Semin Urol 6: 22
4. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569-573
5. Blackburn EH (1992) Telomerases. Annu Rev Biochem 61: 113-129
6. Blackburn EH (1994) Telomeres: no end in sight. Cell 77: 621 623
7. Blasco MA. Rizen M. Greider CW. Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA durinc multi-stage tumorigenesis. Nature Genet 12: 200-204 "
8. Bryan TM. Englezou A. Gupta J Bacchetti S. Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248
9. Carpinito GA. Stadler WM. Briggman JV. Chodak GW. Church PA. Lamm DE. Eange PH."Messing EM. Pasciak RM, Reservit? GB. Ross RN. Rukstalis DB, Sarosky MF. Soloway MS. Thiel RP. Vogelzang N. Hayden CE ( 1996) Urinary nuclear matrix protein as marker for transitional cell carcinoma of urinary tract. J Urol 156: 1280
10. Counter CM. Avilion AA. EeFeuvre CE. Stewart NG. Greider CW. Hartey CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929
11. Counter CM. Hirte HW. Bacchetti S, Harley SB (1994) Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sei USA 91: 2900-2904
12. De Eange T. Shiue E. Myers RM. Cox DR. Naylor SE. Killery AM. Varmus HE (1990) Structure and variability of human chromosome ends. Mol Cell Biol 10: 518 527
13. D'Hatlewin M-A. Baert E (1996) Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475
14. Fett-Conte AC. Liedtke H Jr. Chaves H, Thome JA. Tajara EH (1993) Telomeric fusions in a Wilms' tumor. Cancer Genet Cytogenet 69: 141-145
15. Gamarra MC. Zein T (1984) Cytologie spectrum of bladder cancer. Urology 23 [Suppl 3]: 23
16. Greaves M (1996) Telomerase activation, stem cells and cancer. Trends Genet 12: 127-128
17. Harley CB. Futcher AB. Greider CW ( 1990) Telomeres shorten during aging. Nature 345: 458 460
18. Hastie HD. Dempster M. Dunlop MG. Thompson AM. Green DK, Attshire RC (1990) Telomere reduction in human colorectal carcinoma and with aging. Nature 346: 866- 86X
19. Hiyama E, Yokoyama T. Hiyama K. Yamakido M. Santo T. Kodama T, Ichikawa T, Matsuura Y (1994) Alteration of telomeric repeat length in adult and childhood adult solid neoplasias. Int J Oncol 6: 13-16
20. Hiyama E, Hiyama K. Yokoyama T. Matsuura Y, Piatyszek MA, Shay JW (1995) Correlating telomerase activity levels with human neuroblastma outcomes. Nature Med 1: 249-255
21. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K. Imamura Y, Murakami Y. Kodama T. Piatyszek M, Shay JW. Matsuura Y (1995) Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262
22. Hiyama E, Gollahon L. Kataoka T. Juroi K, Yokoyama T, Gazdar AF, Hiyama K. Piatyszek MA. Shay JW (1996) Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122
23. Holt SE, Shay JW, Wright WE (1996) Refining the telomeretelomerase hypothesis of aging and cancer. Nature Biotechnol 14: 836-839
24. Holt SE, Wright WE, Shay JW (1996) Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932-2939
25. Kavaler E, Shu WP, Change Y, Droller MJ, Liu BCS (1997) Detection of human bladder cancer cells in voided urine samples by assaying for the presence of telomerase activity. J Urol (in press)
26. Kim NW, Piatyszek MA, Prowse KR, Harley CB. West MD. Ho PLC. Coviello GM. Wright WE. Weinrich SL, Shay JW (1994) Spécifie association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
27. Mehle C, Ljung berg B, Roos G (1994) Telomere shortening in renal cell carcinoma. Cancer Res 54: 236-241
28. Nichols G. Khuled Z, Telang NT. Narayanan R (1995) Differentiation of immortal cells inhibits lelomerase activity. Proc Natl Acad Sei USA 92: 12343-12346
29. Ohmura H. Tahara H. Suzuki M. I de T, Shimi/u M. Yoshida MA, Tahara E, Shay JW, Barrett JC. Oshimura M (1995) Restoration of the cellular sensescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86: 899-904
30. Olovinkov AM (1973) A theory of marginotomy. J Theor Biol 41: 181 -190
31. Pathak S. Wang Z. Dhaliwak MK, Sacks PC (1988) Telomeric association: another characteristic of cancer chromosomes? Cytogenet Cell Genet 47: 227-229
32. Rabb SS. Lenel J, Cohen MB (1994) Low grade transitional cell carcinoma of the bladder. Cytologie diagnosis by key features as identified by logistic regression analysis. Cancer 74: 1621
33. Saltman D. Ross FM. Fantes JA. Allshire RC, Turner GE. Evans HG (1989) Telomeric associations in a lymphoblastoid cell line from a patient with B-eell follicular lymphoma. Cytogenet Cell Genet 50: 230-233
34. Sawyer JR. Goosen LS. Stine KC, Thomas JR (1994) Telomeric fusion as a mechanism for the progressive loss of the short arm of chromosome 11 in an anaplastic Wilm's tumor. Cancer 74: 767-773
35. Shay JW. Wright WE (1996) The reactivation of telomerase activity in cancer progression. Trends Genet 12: 129-131
36. Skowronski RJ, Peenl DM. Feldman D (1993) Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952-1960
37. Soloway MS, Briggman JV, Carpinito GA, et al. (1996) Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363
38. Sommerfeld H-J. Meeker AK, Piatyszek MA, Bova GS. Shay JW. Coffey DS (1996) Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222
39. Wright WE, ShayJW (1996) Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2: 799803